Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype

P. Kasparek, Z. Ileninova, O. Zbodakova, I. Kanchev, O. Benada, K. Chalupsky, M. Brattsand, IM. Beck, R. Sedlacek,

. 2017 ; 13 (1) : e1006566. [pub] 20170117

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023353

Netherton syndrome (NS) is a severe skin disease caused by the loss of protease inhibitor LEKTI, which leads to the dysregulation of epidermal proteases and severe skin-barrier defects. KLK5 was proposed as a major protease in NS pathology, however its inactivation is not sufficient to rescue the lethal phenotype of LEKTI-deficient mice. In this study, we further elucidated the in vivo roles of the epidermal proteases in NS using a set of mouse models individually or simultaneously deficient for KLK5 and KLK7 on the genetic background of a novel NS-mouse model. We show that although the ablation of KLK5 or KLK7 is not sufficient to rescue the lethal effect of LEKTI-deficiency simultaneous deficiency of both KLKs completely rescues the epidermal barrier and the postnatal lethality allowing mice to reach adulthood with fully functional skin and normal hair growth. We report that not only KLK5 but also KLK7 plays an important role in the inflammation and defective differentiation in NS and KLK7 activity is not solely dependent on activation by KLK5. Altogether, these findings show that unregulated activities of KLK5 and KLK7 are responsible for NS development and both proteases should become targets for NS therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023353
003      
CZ-PrNML
005      
20170720122236.0
007      
ta
008      
170720s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pgen.1006566 $2 doi
035    __
$a (PubMed)28095415
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kasparek, Petr $u Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic. Faculty of Sciences, Charles University in Prague, Prague, Czech Republic.
245    10
$a KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype / $c P. Kasparek, Z. Ileninova, O. Zbodakova, I. Kanchev, O. Benada, K. Chalupsky, M. Brattsand, IM. Beck, R. Sedlacek,
520    9_
$a Netherton syndrome (NS) is a severe skin disease caused by the loss of protease inhibitor LEKTI, which leads to the dysregulation of epidermal proteases and severe skin-barrier defects. KLK5 was proposed as a major protease in NS pathology, however its inactivation is not sufficient to rescue the lethal phenotype of LEKTI-deficient mice. In this study, we further elucidated the in vivo roles of the epidermal proteases in NS using a set of mouse models individually or simultaneously deficient for KLK5 and KLK7 on the genetic background of a novel NS-mouse model. We show that although the ablation of KLK5 or KLK7 is not sufficient to rescue the lethal effect of LEKTI-deficiency simultaneous deficiency of both KLKs completely rescues the epidermal barrier and the postnatal lethality allowing mice to reach adulthood with fully functional skin and normal hair growth. We report that not only KLK5 but also KLK7 plays an important role in the inflammation and defective differentiation in NS and KLK7 activity is not solely dependent on activation by KLK5. Altogether, these findings show that unregulated activities of KLK5 and KLK7 are responsible for NS development and both proteases should become targets for NS therapy.
650    _2
$a zvířata $7 D000818
650    _2
$a delece genu $7 D017353
650    _2
$a kalikreiny $x genetika $7 D007610
650    _2
$a myši $7 D051379
650    _2
$a Nethertonův syndrom $x genetika $x patologie $7 D056770
650    12
$a fenotyp $7 D010641
650    _2
$a serpiny $x genetika $7 D015843
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ileninova, Zuzana $u Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic.
700    1_
$a Zbodakova, Olga $u Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic.
700    1_
$a Kanchev, Ivan $u Czech Centre for Phenogenomics, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic.
700    1_
$a Benada, Oldrich $u Laboratory of Molecular Structure Characterization, Institute of Microbiology of the Czech Academy of Sciences, v.v.i., Prague, Czech Republic.
700    1_
$a Chalupsky, Karel $u Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic. Czech Centre for Phenogenomics, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic.
700    1_
$a Brattsand, Maria $u Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden.
700    1_
$a Beck, Inken M $u Czech Centre for Phenogenomics, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic.
700    1_
$a Sedlacek, Radislav $u Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic. Czech Centre for Phenogenomics, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i., Vestec, Czech Republic.
773    0_
$w MED00008920 $t PLoS genetics $x 1553-7404 $g Roč. 13, č. 1 (2017), s. e1006566
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28095415 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170720122729 $b ABA008
999    __
$a ok $b bmc $g 1239034 $s 984266
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 13 $c 1 $d e1006566 $e 20170117 $i 1553-7404 $m PLoS genetics $n PLoS Genet $x MED00008920
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace